CN104174004A - Medicament for lowering blood fat - Google Patents

Medicament for lowering blood fat Download PDF

Info

Publication number
CN104174004A
CN104174004A CN201410461385.1A CN201410461385A CN104174004A CN 104174004 A CN104174004 A CN 104174004A CN 201410461385 A CN201410461385 A CN 201410461385A CN 104174004 A CN104174004 A CN 104174004A
Authority
CN
China
Prior art keywords
parts
medicament
folium
semen
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410461385.1A
Other languages
Chinese (zh)
Inventor
彭海明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410461385.1A priority Critical patent/CN104174004A/en
Publication of CN104174004A publication Critical patent/CN104174004A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for lowering blood fat. The medicament is prepared from the following substances in parts by weight: 10-30 parts of astragalus, 20-50 parts of semen raphani, 10-15 parts of ligusticum wallichii, 5-10 parts of radix scrophulariae, 10-20 parts of dried ginger, 20-30 parts of fructus corni, 10-20 parts of platycodon grandiflorum, 15-25 parts of coptidis rhizome, 5-15 parts of chrysanthemum, 8-15 parts of henbane, 10-20 parts of ephedra, 15-30 parts of pyrrosia lingua, 10-20 parts of morinda officinalis, 10-25 parts of greater celandine herb, 10-25 parts of gallnut, 10-20 parts of polygonum cuspidatum, 15-20 parts of murraya jasminorage, 10-20 parts of kaladana, 15-20 parts of Japanese inula herb, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 5-10 parts of semen plantaginis, 15-25 parts of folium rhododendri daurici, 10-20 parts of physalis permviana, 10-20 parts of glossy privet fruit and 10-30 parts of phyllanthus emblica. All ingredients of the medicament for lowering blood fat are natural medicines, and thus, the medicament has the advantages of high effect taking speed, good curative effect and no toxic or side effect, and is clear in curative effect and suitable for being clinically popularized on a large scale.

Description

A kind of medicament of blood fat reducing
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament of blood fat reducing.
Background technology
Hyperlipemia mainly refers to serum total cholesterol or triglyceride levels is too high and Serum High-Density Lipoprotein-Cholesterol level is too low.Hyperlipemia is person in middle and old age's commonly encountered diseases and frequently-occurring disease, and along with the raising of people's living standard and the change of living habit, this sick sickness rate obviously increases, and the age of morbidity also shifts to an earlier date to some extent.So the treatment of hyperlipemia is extremely important, this has caused showing great attention to of the whole mankind.The final purpose for the treatment of hyperlipemia is to suppress arteriosclerotic further developing, thereby prevents the death that caused by cardio-cerebrovascular diseases.
Summary of the invention
The object of the invention is exactly in order to make up the defect of prior art, provide a kind of blood fat reducing medicament, specifically by making in following raw material medicaments in part by weight: Radix Astragali 10-30 part, Semen Raphani 20-50 part, Rhizoma Chuanxiong 10-15 part, Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Semen Hyoscyami 8-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Radix Morindae Officinalis 10-20 part, Rhizoma Polygoni Cuspidati 10-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Folium Sennae 10-25 part, Folium Rhododendri Daurici 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Fructus Ligustri Lucidi 10-20 part and Fructus Phyllanthi 10-30 part.
Preferably, it is to be made by weight by following bulk drugs: 30 parts of 15 parts of the Radixs Astragali, 25 parts of Semen Raphanis, 10 parts of Rhizoma Chuanxiongs, 8 parts of Radix Scrophulariaes, 15 parts of Rhizoma Zingiberiss, 20 parts of Fructus Corni, 10 parts of Radix Platycodoniss, 20 parts of Rhizoma Coptidis, 10 parts of Flos Chrysanthemis, 10 parts of Semen Hyoscyamis, 15 parts, Herba Ephedrae, 20 parts of Folium Pyrrosiaes, 15 parts of Radix Morindae Officinaliss, 15 parts of Rhizoma Polygoni Cuspidati, 20 parts of Folium Et Cacumen Murrayae, 10 parts of Semen Pharbitidiss, 20 parts of Herba Inulae, 15 parts of Folium Sennae, 20 parts of Folium Rhododendri Daurici, 15 parts of Calyx Seu Fructus Physaliss, 15 parts of Fructus Ligustri Lucidi and Fructus Phyllanthis.
Preferably, described medicament is dispersible tablet, molten, tablet, powder or granule.
The present invention also provides a kind of preparation method of medicament of blood fat reducing, the method comprises: get 15 parts of the Radixs Astragali, 25 parts of Semen Raphanis, 10 parts of Rhizoma Chuanxiongs, 8 parts of Radix Scrophulariaes, 15 parts of Rhizoma Zingiberiss, 20 parts of Fructus Corni, 10 parts of Radix Platycodoniss, 20 parts of Rhizoma Coptidis, 10 parts of Flos Chrysanthemis, 10 parts of Semen Hyoscyamis, 15 parts, Herba Ephedrae, 20 parts of Folium Pyrrosiaes, 15 parts of Radix Morindae Officinaliss, 15 parts of Rhizoma Polygoni Cuspidati, 20 parts of Folium Et Cacumen Murrayae, 10 parts of Semen Pharbitidiss, 20 parts of Herba Inulae, 15 parts of Folium Sennae, 20 parts of Folium Rhododendri Daurici, 15 parts of Calyx Seu Fructus Physaliss, 30 parts of 15 parts of Fructus Ligustri Lucidi and Fructus Phyllanthis, pulverize, cross 100 mesh sieves, then add 500 grams, crystal sugar, mix, pack in 100 bags and get final product.
Whole compositions of the medicament of blood fat reducing of the present invention are all natural drugs, so it has advantages of instant effect, good effect, has no side effect, and curative effect is clear and definite, is suitable for large-scale promotion clinically.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get 30 parts of 15 parts of the Radixs Astragali, 25 parts of Semen Raphanis, 10 parts of Rhizoma Chuanxiongs, 8 parts of Radix Scrophulariaes, 15 parts of Rhizoma Zingiberiss, 20 parts of Fructus Corni, 10 parts of Radix Platycodoniss, 20 parts of Rhizoma Coptidis, 10 parts of Flos Chrysanthemis, 10 parts of Semen Hyoscyamis, 15 parts, Herba Ephedrae, 20 parts of Folium Pyrrosiaes, 15 parts of Radix Morindae Officinaliss, 15 parts of Rhizoma Polygoni Cuspidati, 20 parts of Folium Et Cacumen Murrayae, 10 parts of Semen Pharbitidiss, 20 parts of Herba Inulae, 15 parts of Folium Sennae, 20 parts of Folium Rhododendri Daurici, 15 parts of Calyx Seu Fructus Physaliss, 15 parts of Fructus Ligustri Lucidi and Fructus Phyllanthis, pulverize, cross 100 mesh sieves, then add 500 grams, crystal sugar, mix, pack in 100 bags and get final product.
Experimental example
This group of clinical data 80 cases, all meet hyperlipemia diagnostic criteria (the dyslipidemia diagnostic criteria that < < China cardiovascular magazine > > editorial board 2/2 page of dyslipidemia Preventing Countermeasures special topic group of explanation CN 102205046 A book CN 102205047 A is formulated) [Chinese Journal of Cardiology editorial board. dyslipidemia Preventing Countermeasures special topic group. dyslipidemia control suggestion [J]. Chinese Journal of Cardiology, 1997,25 (3): 169.], male 40 examples wherein, female's 40 examples; 25~75 years old age, average 50 years old.
With the medicine making in embodiment 1, treat, wherein one day 3 times, each one bag, treating 3 months is a course for the treatment of.
With reference to < < new Chinese medicine guideline of clinical investigations > > (Zheng Xiao cornel. new Chinese medicine guideline of clinical investigations (trying) [S]. Beijing. Chinese Medicine science and technology publishing house, 2002:85~89.) work out criterion of therapeutical effect.Respectively before and after treatment all on an empty stomach after 12h in venous blood samples in early morning, measure the indices such as TC, TG, LDL-C, HDL-C, conscience, renal function and blood, urine, stool routine.Effective: lipids detection reaches following any one person: TC decline >=20%, TG and declines >=40%.HDL-C rising >=0.26mmol/L, TC-LDL-C/HDL-C >=20%.Effective: lipids detection reaches following any one person: TC and declines >=10% but < 20%, TG declines >=20% but < 40%.HDL-C rising >=0.104mmol/L but < 0.26mmol/L, TC-LDL-C/HDL-C >=10% but < 20%.Invalid: lipids detection does not reach above standard person.
Through there being the observation of a course for the treatment of, find that there is 70 patient treatment effects effective, 10 patient treatment effects are effective, and total effective rate rate is 100%, and during whole treatment, does not observe obvious untoward reaction.
After treating a course for the treatment of, all patient is followed up a case by regular visits to weekly, continue 1 year, find the sign of recurrence.

Claims (3)

1. the medicament of a blood fat reducing, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Astragali 10-30 part, Semen Raphani 20-50 part, Rhizoma Chuanxiong 10-15 part, Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Semen Hyoscyami 8-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Radix Morindae Officinalis 10-20 part, Rhizoma Polygoni Cuspidati 10-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Folium Sennae 10-25 part, Folium Rhododendri Daurici 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Fructus Ligustri Lucidi 10-20 part and Fructus Phyllanthi 10-30 part.
2. the medicament of blood fat reducing according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 30 parts of 15 parts of the Radixs Astragali, 25 parts of Semen Raphanis, 10 parts of Rhizoma Chuanxiongs, 8 parts of Radix Scrophulariaes, 15 parts of Rhizoma Zingiberiss, 20 parts of Fructus Corni, 10 parts of Radix Platycodoniss, 20 parts of Rhizoma Coptidis, 10 parts of Flos Chrysanthemis, 10 parts of Semen Hyoscyamis, 15 parts, Herba Ephedrae, 20 parts of Folium Pyrrosiaes, 15 parts of Radix Morindae Officinaliss, 15 parts of Rhizoma Polygoni Cuspidati, 20 parts of Folium Et Cacumen Murrayae, 10 parts of Semen Pharbitidiss, 20 parts of Herba Inulae, 15 parts of Folium Sennae, 20 parts of Folium Rhododendri Daurici, 15 parts of Calyx Seu Fructus Physaliss, 15 parts of Fructus Ligustri Lucidi and Fructus Phyllanthis.
3. the medicament of blood fat reducing according to claim 1, is characterized in that, described medicament can be dispersible tablet, molten, tablet, powder or granule.
CN201410461385.1A 2014-09-11 2014-09-11 Medicament for lowering blood fat Pending CN104174004A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410461385.1A CN104174004A (en) 2014-09-11 2014-09-11 Medicament for lowering blood fat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410461385.1A CN104174004A (en) 2014-09-11 2014-09-11 Medicament for lowering blood fat

Publications (1)

Publication Number Publication Date
CN104174004A true CN104174004A (en) 2014-12-03

Family

ID=51955532

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410461385.1A Pending CN104174004A (en) 2014-09-11 2014-09-11 Medicament for lowering blood fat

Country Status (1)

Country Link
CN (1) CN104174004A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113424882A (en) * 2021-08-05 2021-09-24 山西中医药大学 Preparation method of astragalus membranaceus lipid-lowering tea bag
CN116077576A (en) * 2022-09-20 2023-05-09 福建省华杭生物科技开发有限公司 Gynostemma pentaphylla hypolipidemic medicament formula

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102205046A (en) * 2011-05-11 2011-10-05 李�杰 Medicament for reducing blood fat
CN103142975A (en) * 2013-03-22 2013-06-12 孙秋菊 Medicament for reducing blood fat

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102205046A (en) * 2011-05-11 2011-10-05 李�杰 Medicament for reducing blood fat
CN103142975A (en) * 2013-03-22 2013-06-12 孙秋菊 Medicament for reducing blood fat

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113424882A (en) * 2021-08-05 2021-09-24 山西中医药大学 Preparation method of astragalus membranaceus lipid-lowering tea bag
CN116077576A (en) * 2022-09-20 2023-05-09 福建省华杭生物科技开发有限公司 Gynostemma pentaphylla hypolipidemic medicament formula

Similar Documents

Publication Publication Date Title
CN102755594A (en) Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof
CN1985922B (en) Medicine composition for treating common cold and its preparing method
CN102727706A (en) Composition for preventing and treating diabetes
CN102397372A (en) Medicinal composition and pharmaceutical preparation and application thereof to treating irritable bowel syndrome
Qu et al. Mongolian medicine: History, development and existing problems
CN102205046B (en) Medicament for reducing blood fat
CN102579658A (en) Traditional Chinese medicinal composition for curing hyperuricacidemia, gout and urinary retention
CN101406598B (en) Chinese medicine composite for treating diabetes and preparation method thereof
CN104174004A (en) Medicament for lowering blood fat
CN102671060A (en) Medicinal composition for treating gout and preparation method thereof
CN100348235C (en) Traditional Chinese medicine preparation for treating infantile diarrhea and preparation method thereof
CN102309624A (en) Traditional Chinese medicine oral liquid for preventing and treating dorking influenza and preparation method thereof
CN106543249A (en) It is a kind of that the preparation method for preventing and treating hyperuricemia and the medicinal monomer of gout is extracted from Rhizoma Polygoni Cuspidati
CN103977390B (en) A kind of preparation method and its usage of ginger onion medicated wine composition
CN114404538B (en) Traditional Chinese medicine composition for treating gouty arthritis and application thereof
CN102727753A (en) Traditional Chinese medicine composition used for treating gout, and preparation method and application thereof
CN102764294A (en) Cough relieving and sputum eliminating combination and preparation method thereof
CN101732585A (en) Medicinal composition for treating migraine, preparation method and application thereof
CN105327115B (en) A kind of prevention and treatment type II diabetes Phellinus is logical to rush down formula and preparation process
CN103142975B (en) Medicament for reducing blood fat
CN1943658B (en) A Chinese traditional medicinal composition for treating acute, chronic hepatitis and preparing method
CN103948736B (en) The compound Chinese medicinal preparation for the treatment of hepatocarcinoma and production method thereof
CN108743885A (en) A kind of Chinese medicine and preparation method thereof for treating Diabetic Macrovascular Complications
CN108514627A (en) A kind of Chinese medicine composition for treating chronic urticaria
CN103127358B (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141203